Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01161238 · ClinicalTrials.gov registry record
Amputee Residual Limb Volume Fluctuation
A clinical trial, sponsored by University of Washington.
- Completed
- Registry status
- 28
- Enrollment target
NCT01161238: Completed study, sponsored by University of Washington.
NCT01161238 is a clinical trial that has completed, run by University of Washington. The registered enrollment target is 28 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01161238 has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- 28 participants
- Enrollment target
Study Summary
The goal of this project is a useful clinical instrument for diagnosis and treatment of residual limb volume fluctuation in individuals who use prosthetic limbs. One hypothesis to be tested is that the instrument effectively measures short and long term volume fluctuations in individuals with trans-tibial amputation. Another hypothesis to be tested is that when subjects add a sock or insert to the prosthesis residual limb volume decreases, and when they remove the sock or insert residual limb volume increases.
Interventions
- OTHER Monitored for limb volume
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2010-05 |
| Est. Completion | 2011-09 |
What the finished NCT01161238 record still lists
NCT01161238 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 28 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Monitored for limb volume is the first listed.
NCT01161238 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01161238 about?
NCT01161238 is a clinical study titled "Amputee Residual Limb Volume Fluctuation". The goal of this project is a useful clinical instrument for diagnosis and treatment of residual limb volume fluctuation in individuals who use prosthetic limbs. One hypothesis to be tested is that the instrument effectively measures short and long term volume fluctuations in individuals with trans-...
What is the current status of trial NCT01161238?
This trial is currently completed. The enrollment target is 28 participants. The study started on 2010-05. Estimated completion is 2011-09.
What interventions are being tested in trial NCT01161238?
The interventions under investigation include: Monitored for limb volume (OTHER).
Who is sponsoring clinical trial NCT01161238?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia